Editorial: Beyond Red Light, Green Light: Examining the Role of Pharmacogenomics in Evidence-Based Care in Child and Adolescent Psychiatry
- 10 November 2021
- journal article
- editorial
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 61 (1) , 29-31
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A Randomized, Double-Blind, Placebo-Controlled Trial of Vilazodone in Children and Adolescents with Major Depressive Disorder with Twenty-Six-Week Open-Label Follow-UpJournal of Child and Adolescent Psychopharmacology, 2020
- Pharmacogenomics: an Update for Child and Adolescent PsychiatryCurrent Psychiatry Reports, 2020
- The Influence of Pharmacodynamic Genes on Fluoxetine Response in Pediatric Anxiety and Depressive DisordersJournal of Child and Adolescent Psychopharmacology, 2020
- Pharmacogenetics of Sertraline Tolerability and Response in Pediatric Anxiety and Depressive DisordersJournal of Child and Adolescent Psychopharmacology, 2019
- Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled studyJournal of Psychiatric Research, 2019
- Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive DisordersFrontiers in Pharmacology, 2019
- UTILIZATION OF CYP450 GENOTYPING IN THE TREATMENT OF ADOLESCENT MOOD DISORDERS: A LOOK AT THE IMPACT WITHIN AN OUTPATIENT SETTINGJournal of the American Academy of Child & Adolescent Psychiatry, 2018
- On the Marketing and Use of Pharmacogenetic Tests for Psychiatric TreatmentJAMA Psychiatry, 2018
- Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive DisorderJournal of Child and Adolescent Psychopharmacology, 2018
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake InhibitorsClinical Pharmacology & Therapeutics, 2015